Family Medicine · Bronx, NY
NPI
1043434731
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
820 E Tremont Ave
Bronx, NY, 10460
Phone (718) 466-4662
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
6,723 prescriptions
Company payments, 2025
$2,415
From 24 companies
Medicare prescription drug claims, 2024
In 2024, the drug Nader R Hanna prescribed most often to Medicare patients was Atorvastatin Calcium, with 706 prescriptions and refills. In total Nader R Hanna wrote 6,723 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 706 | 1,269 | 152 | $6,191 |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 336 | 643 | 80 | $11K |
| Amlodipine Besylate Generic | 258 | 432 | 51 | $1,070 |
| Metformin Hcl Generic | 225 | 345 | 41 | $34K |
| Omeprazole Generic | 219 | 262 | 49 | $1,759 |
| Farxiga Dapagliflozin Propanediol | 210 | 273 | 41 | $150K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 158 | 312 | 43 | $3,058 |
| Diclofenac Sodium Generic | 155 | 155 | 62 | $29K |
| Nifedipine Er Nifedipine | 152 | 286 | 37 | $2,033 |
| Janumet Sitagliptin Phos/Metformin Hcl | 131 | 141 | 17 | $77K |
| Alendronate Sodium Generic | 126 | 193 | 21 | $259 |
| Doxepin Hcl Generic | 126 | 130 | 39 | $13K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 124 | 131 | 25 | $3,567 |
| Metoprolol Tartrate Generic | 124 | 202 | 25 | $186 |
| Metoprolol Succinate Generic | 124 | 194 | 25 | $1,015 |
Brand drugs: 1,542 claims; generic drugs: 4,831 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nader R Hanna $2,415 ($2,415 in general payments such as food, travel and fees) from 24 companies. The largest payer was Abbvie Inc. with $873.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 27 | $873 |
| Novo Nordisk Inc NVO | 11 | $218 |
| Ardelyx, Inc. ARDX | 9 | $188 |
| Kowa Pharmaceuticals America, Inc. | 12 | $175 |
| Merck Sharp & Dohme LLC MRK | 7 | $137 |
| Phathom Pharmaceuticals, Inc. PHAT | 1 | $125 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 6 | $123 |
| Shield Therapeutics Inc STX.L | 4 | $80.6 |
| Axsome Therapeutics, Inc. AXSM | 3 | $64.72 |
| Amgen Inc. AMGN | 2 | $44.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.